Top Markets
Coin of the day
Gentian Diagnostics AS Gentian Diagnostics AS

Gentian Diagnostics AS

GENT
株式のランク #24261
Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents... Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents for use in medical diagnostics and research in the United States, Asia, and Europe. It offers in-vitro diagnostic reagents for clinical chemistry analyzers, such as Gentian Calprotectin Immunoassay, a turbidimetric assay used for the measurement of circulating calprotectin in plasma and serum for detection and assessment of inflammation; Gentian Cystatin C Immunoassay test kit, a GFR marker for the diagnosis and therapeutic control of renal function and chronic kidney disease; Gentian Retinol-Binding Protein Immunoassay for detection of retinol-binding protein in human serum and plasma; and Canine CRP Immunoassay test kit, a particle-enhanced turbidimetric immunoassay for quantitative determination of canine C-reactive protein in dog plasma and serum. The company also develops faecal calprotectin immunoassay turbo that offers results of calprotectin concentration in stool supporting diagnosis of inflammatory bowel disease; and faecal pancreatic elastase immunoassay turbo, which allows analysis of pancreatic elastase in stool to aid in diagnosis of pancreatic exocrine insufficiency. Gentian Diagnostics ASA was founded in 2001 and is headquartered in Moss, Norway.
株価
$4.07
最終同期: 2026-08-21
時価総額
$62.87M
変化(1日)
3.19%
変化(1年)
-28.25%
NO
取引 Gentian Diagnostics AS (GENT)

カテゴリー

Gentian Diagnostics AS(GENT)の配当利回りの履歴
Gentian Diagnostics AS(銘柄コード: GENT)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Gentian Diagnostics AS(GENT)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)